News
Intersection / Topic
gilead mercks phase 3 data back first weekly hiv pill
Rank map, news, and discussion for gilead mercks phase 3 data back first weekly hiv pill. · United States · Snapshot day 2026-07-23
Based on 2 labeled outlet(s) in news hits (L0/C2/R0). Outlet often aims for mixed/center coverage in public media-bias surveys. Still verify claims yourself.
Today’s ranks
| Platform | Rank | Matching item |
|---|---|---|
| — | Not in today’s top list | |
| Bing | — | Not in today’s top list |
| YouTube | — | Not in today’s top list |
| X | — | Not in today’s top list |
| Poly | — | Not in today’s top list |
| TikTok | — | Not in today’s top list |
| FB | — | Not in today’s top list |
| IG | — | Not in today’s top list |
Open in…
News hits
-
1
Gilead, Merck’s phase 3 data back first weekly HIV pill - Fierce Pharma
Google News
Google News · Fierce Pharma Unclear -
2
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy - Business Wire
Google News
Google News · Business Wire Unclear -
3
Merck, Gilead serve ‘sweet and sour’ spread after HIV win, cancer stumble - BioSpace
Google News
Google News · BioSpace Unclear -
4
Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure - Business Wire
Google News
Google News · Business Wire Unclear -
5
Switch to single-tablet bictegravir–lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial - The Lancet
Google News
Google News · The Lancet Unclear -
6
Gilead's lung cancer bid for Trodelvy hits wall, but HIV studies deliver better news - FirstWord Pharma
Google News
Google News · FirstWord Pharma Unclear -
7
New antiretrovirals in the pipeline could be part of twice-yearly HIV treatment - Aidsmap
Google News
Google News · Aidsmap Mixed / center -
8
Gilead-MSD once-weekly oral HIV regimen meets Phase III endpoints - European Pharmaceutical Review
Google News
Google News · European Pharmaceutical Review Unclear -
9
Gilead to present data on potential first weekly oral treatment for HIV - Clinical Trials Arena
Google News
Google News · Clinical Trials Arena Unclear -
10
Merck, Gilead share positive phase 3 results from combination HIV pill - Seeking Alpha
Google News
Google News · Seeking Alpha Unclear -
11
New Long Acting Oral HIV Regimen Meets Primary Endpoints In Phase 3 Trials - NDTV
Google News
Google News · NDTV Unclear -
12
Top 5 stories on the future of HIV treatment from CROI 2026 - Aidsmap
Google News
Google News · Aidsmap Mixed / center -
13
Gilead, Merck’s phase 3 data back first weekly HIV pill
Detailed phase 3 results suggest the two-drug combination of Gilead Sciences’ lenacapavir and Merck & Co.’s islatravir has what it takes to become the first com…
Bing News Unclear
Topic pages combine today’s rank map, free news indexes, and public comments. Lean badges use curated outlet labels — not a fact-check or endorsement. Not affiliated with listed platforms. Be civil — comments are public.
Discussion 0 · optional name or Anonymous